The effect of N-nitro-L-arginine methyl ester on morphine-induced changes in the plasma corticosterone and testosterone levels in mice

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 1, 1999, Pages 75-79

  Budziszewska, B ^a   Leskiewicz M ^a   Jaworska Feil, L ^a   Lason W ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Corticosterone; L NAME; Mice; Morphine; Nitric oxide; Testosterone

Indexed keywords

CORTICOSTERONE; MORPHINE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE TIME EFFECT RELATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

EID: 0033036244     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212077     Document Type: Article

References (31)

1. Adams ML, Meyer ER, Cicero TJ: Effects of nitric oxide-related agents on opioid regulation of rat testicular steroidogenesis. Biol Reprod 54: 1128-1134, 1996
2. Adams ML, Meyer ER, Sewing BN, Cicero TJ: Effects of nitric oxide-related agents on rat testicular function. J Pharmacol Exp Ther 269: 230-237, 1994
3. G-nitro-L-arginine and comparisons to alkohol. Life Sci 50: PL35-PL40, 1992
4. Buckingham JC: Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides. Neuroendocrinology 35: 111-116, 1982
5. Buckingham JC, Cooper TA: Pharmacological characterization of opioid receptors influencing the secretion of corticotrophin releasing factor in the rat. Neuroendocrinology 44: 36-40, 1986
6. Budziszewska B, Jaworska L, Lasoń W: Repeated morphine administration down-regulates glucocorticoid, but not mineralocorticoid receptors in the rat hippocampus. Psychoneuroendocrinology 20: 75-81, 1995
7. Budziszewska B, Jaworska-Feil L, Lasoń W: Neurosteroids and the naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Eur Neuropsychopharmacol 6: 135-140, 1996
8. Bugajski J, Borycz J, Ga̧dek-Michalska A, Głód R, Bugajski AJ: Mediation by nitric oxide of the carbachol-induced corticosterone secretion in rats. J Physiol Pharmacol 48: 277-284, 1997a
9. Bugajski J, Ga̧dek-Michalska A, Ołowska A, Borycz J, Głód R: Role of nitric oxide in the vasopressin-induced corticosterone secretion in rats. J Physiol Pharmacol 48: 805-812, 1997b
10. Canteros G, Rettori V, Franchi A, Genaro A, Cebral E., Faletti A, Gimeno M, McCann SM: Ethanol inhibits luteinizing hormone-releasing hormone (LHRH) secretion by blocking the response of LHRH neuronal terminals to nitric oxide. Proc Natl Acad Sci USA 92: 3416-3420, 1995
11. Cappendijk SLT, de Vries R, Dzoljic MR: Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci Lett: 162, 97-100, 1993
12. Ceccatelli S, Hulting AL, Zhang X, Gustafsson L, Villar M, Hokfelt T: Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. Proc Natl Acad Sci USA 90: 11292-11296, 1993
13. Cella SG, Locatelli V, Muller EE: Opioid peptides in the regulation of anterior pituitary hormones. In: Herz A (ed.) Handbook of Experimental Pharmacology, vol. 104/11., Opioids II, pp. 473-495, Springer-Verlag, Berlin, Heidelberg, 1993
14. Del Punta K, Charreau EH, Pignataro OP: Nitric oxide inhibits Leydig cell steroidogenesis. Endocrinology 137: 5337-5343, 1996
15. Giordano M, Vermulen M, Trevani AS, Dran G, Andonegui G, Geffner JR: Nitric oxide synthase inhibitors enhance plasma level of corticosterone and ACTH. Acta Physiol Scand 157: 259-264, 1996
16. Höllt V, Przewlocki R, Herz A: β-endorphin like immunoreactivity in plasma, pituitaries and hypothalamus of rats following treatment with opiates. Life Sci 23: 1057-1066, 1978
17. Ignar DM, Kuhn CM: Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat. J Pharmacol Exp Ther 255: 1287-1295, 1990
18. Karanth S, Lyson K, McCann SM: Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci USA 90: 3383-3387, 1993
19. Kiem DT, Bartha L, Makara GB: Effect of dexamethasone implanted in different brain areas on the morphine-induced PRL, GH and ACTH/corticosterone secretion. Brain Res 563: 107-113, 1991
20. Kimes AS, Vaupel DB, London ED: Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology: 112, 521-524, 1993
21. G-nitro-L-arginine prevents morphine tolerance. Eur J Pharmacol 221: 399-400, 1992
22. Machelska H, Łabuz D, Przewłocki R, Przewłocka B: Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. J Pharmacol Exp Ther 282: 977-984, 1997
23. Majeed NH, Przewłocka B, Machelska H, Przewłocki R: Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology 33: 189-192, 1994
24. Millan M, Herz A: The endocrinology of opioids. International Rev Neurobiol 26: 1-83, 1985
25. Milanes MV, Puig MM, Vargas ML: Simultaneous changes in hypothalamic catecholamine levels and plasma corticosterone concentration in the rat after acute morphine and during tolerance. Neuropeptides 24: 279-284, 1993
26. Przegaliński E, Budziszewska B, Grochmal A: Effect of adenosine analogues on plasma corticosterone concentration in rats. Acta Endocrinol 127: 471-475, 1992
27. Raber J, Koob GF, Bloom FE: Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. J Pharmacol Exp Ther 272: 815-824, 1995
28. Rauhala P, Idanpaan-Heikkila JJ, Tuominen RK, Mannisto PT: N-nitro-L-arginine attenuates development of tolerance to antinociceptive but not to hormonal effects of morphine. Eur J Pharmacol 259: 57-64, 1994
29. Snyder GD, Holmes RW, Bates JN, Van Voorhis BJ: Nitric oxide inhibits aromatase activity: mechanisms of action. J Steroid Biochem Molec Biol 58: 63-69, 1996
30. Vaupel DB, Kimes AS, London ED: Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal. Psychopharmacology: 118, 361 -368, 1995
31. Welch C, Watson ME, Poth M, Hong T, Francis GL: Evidence to suggest nitric oxide is an interstitial regulator of Leydig cell steroidogenesis. Metabolism 44: 234-238, 1995